LGX 818 10mg 10mg | Purity Not Available
Adooq Bioscience
LGX818 is an orally available Raf kinase inhibitor with potential antineoplastic activity.
More Information Supplier PageLGX818 is an orally available Raf kinase inhibitor with potential antineoplastic activity.
More Information Supplier PageLGX818 is an orally available Raf kinase inhibitor with potential antineoplastic activity.
More Information Supplier PageSGC-CBP30 is a potent and selective inhibitor of CREBBP (CBP) and EP300; which are general transcriptional co-activators.
More Information Supplier PageSGC-CBP30 is a potent and selective inhibitor of CREBBP (CBP) and EP300; which are general transcriptional co-activators.
More Information Supplier Page